Galapagos Announces Major Stake by EcoR1 Capital
Galapagos Receives Transparency Notification From EcoR1 Capital, Now Holding 10.19% Of Galapagos' Voting Rights Through Acquisition Of 6.71M Shares; EcoR1 Capital Crosses 10% Threshold As Of September 10, 2024
Galapagos Analyst Ratings
Express News | Galapagos NV : Leerink Partners Initiates Coverage With Market Perform Rating; Target Price $24
FMR LLC Reduces Stake in Galapagos Company
Pioneering Haircare Brand Rhyme & Reason Urge Consumers to Take Action Under the Rallying Cry of 'NO NEW PLASTIC'
Even After Rising 13% This Past Week, Galapagos (AMS:GLPG) Shareholders Are Still Down 82% Over the Past Five Years
Galapagos up 10% as Major Shareholder Intends to Talk About Strategy
Major Investor Says Galapagos Is 'Undervalued,' Plans To Push On Company's 'Performance' And 'Strategic Opportunities'
Galapagos NV Up Over 11%, on Pace for Largest Percent Increase Since January 2022 -- Data Talk
Galapagos, XPeng, CorMedix And Other Big Stocks Moving Higher On Monday
Morgan Stanley Sticks to Its Hold Rating for Galapagos (GLPG)
Galapagos Shares Are Trading Higher After Ecor1 Capital Reported a 9.9% Stake in the Company.
Ecor1 Capital Reported A 9.9% Stake In Galapagos On Friday In A 13D Filing
Why MIRA Pharmaceuticals Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket
Sector Update: Health Care Stocks Rise Premarket Friday
Sector Update: Health Care
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Friday as Investors Hope for Dovish Powell Remarks
Galapagos Secures US FDA OK for Clinical Trial of Non-Hodgkin Lymphoma Drug
FDA Clears Galapagos' IND Application For Phase 1/2 Study Of GLPG5101 In R/R Non-Hodgkin Lymphoma